Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT05725590

A Multicenter Randomized Controlled Study of External Pancreatic Duct Stents in Pancreaticoduodenectomy

Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2023-02-13

300

Participants Needed

1

Research Sites

182 weeks

Total Duration

On this page

Sponsors

S

Second Affiliated Hospital, School of Medicine, Zhejiang University

Lead Sponsor

N

Ningbo No. 1 Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

The prognostic value of external vs internal pancreatic duct stents after pancreaticoduodenectomy remains controversial. This study aimed to evaluate the benefits of external and internal stents using the Updated Alternative Fistula Risk Score in both high-risk and low-risk patients with regard to the incidence of clinically relevant postoperative pancreatic fistula.

CONDITIONS

Official Title

A Multicenter Randomized Controlled Study of External Pancreatic Duct Stents in Pancreaticoduodenectomy

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Pancreatoduodenectomy with pancreaticojejunal mucosa anastomosis was performed
  • No combined organic diseases in the heart, lungs, or kidneys
  • No history of chemotherapy, radiotherapy, upper abdominal surgery, or other tumors
  • Updated Alternative Fistula Risk Score (ua-FRS) higher than 5%
Not Eligible

You will not qualify if you...

  • Previous history of other tumors or upper abdominal surgery
  • Multiple lesions and distant metastasis
  • Organic diseases of important organs such as heart, lung, or kidney preventing surgery
  • Age less than 18 years or older than 75 years
  • Use of other measures to prevent pancreatic fistula, such as fibrin glue sealing, that may affect the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

Hangzhou, China

Actively Recruiting

Loading map...

Research Team

S

Sheng Yan, Doctor

CONTACT

G

Guogang Li, Doctor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here